Skip to main content
Log in

Polkörperdiagnostik

Moderner Mythos oder überzeugende Hilfe bei IVF und ICSI?

Polar body diagnosis

Modern myth or effective aid in IVF and ICSI?

  • Leitthema
  • Published:
Gynäkologische Endokrinologie Aims and scope

Zusammenfassung

Unter Polkörperdiagnostik (PKD) versteht man die Untersuchung der im Zuge der meiotischen Reifeteilung entstandenen Polkörper der Eizelle auf genetische Dispositionen oder auf numerische bzw. strukturelle Veränderungen der Chromosomen. Die Ergebnisse der PKD erlauben einen Rückschluss auf die genetische/chromosomale Situation der Eizelle. Das Haupteinsatzgebiet der PKD ist das Aneuploidiescreening zum Nachweis von numerischen Chromosomenfehlverteilungen in Eizellen bei fortgeschrittenem mütterlichem Alter oder bei wiederholtem Implantationsversagen. Daten zum Aneuploidiescreening aus kontrollierten randomisierten Studien liegen derzeit nur in Verbindung mit der Embryobiopsie vor. Die zum Teil kontroversen Ergebnisse werden vor dem Hintergrund gesehen, dass Embryonen Mosaike aufweisen können und daher für diesbezügliche Untersuchungen ungeeignet sind. Inzwischen wird die PKD auch international als der möglicherweise aussichtsreichere Weg zur Diagnostik von chromosomalen Fehlverteilungen eingeschätzt. Die Strategie ist hierbei die Biopsie des ersten und zweiten Polkörpers mit nachfolgender Untersuchung aller Chromosomen mittels der Array-CGH. Diese Technik wird im Rahmen einer Pilotstudie derzeit auch in Deutschland eingesetzt.

Abstract

Polar body diagnosis is the investigation of the by-products of the meiotic cell cycle, the first and second polar bodies, regarding genetic dispositions or structural and/or numerical chromosomal disorders. The results of polar body diagnosis allow conclusions to be drawn on the genetic/chromosomal constitution of the oocyte. The major application of polar body diagnosis is pre-implantation genetic screening (PGS) to detect numerical chromosomal disorders in oocytes from women with advanced maternal age or in cases with repeated implantation failure. To date all published randomized controlled trials on PGS were done by embryo biopsy. The controversial results of these studies need to be seen in view of mosaicism which is frequent in early embryos. Consequently one may conclude that the early cleavage stage embryo is not a suitable target for those kinds of investigations. Meanwhile, polar body diagnosis is considered to be the better option for the diagnosis of numerical chromosomal disorders. The strategy is to biopsy the first and second polar bodies followed by investigation of all chromosomes using array CGH. This technique is already being used in Germany in the context of a pilot study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Anderson R, Pickering S (2008) The current status of preimplantation genetic screening: British Fertility Society Policy and Practice Guidelines. Hum Fertil 11:71–75

    Article  Google Scholar 

  2. ASRM (2008) Preimplantation genetic testing: a practice committee opinion. Fertil Steril 90(Suppl):S136–S143

    Google Scholar 

  3. Baart EB, Martini E, Berg I van den et al (2006). Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF. Hum Reprod 21:223–233

    Article  CAS  PubMed  Google Scholar 

  4. Blockeel C, Schutyser V, De Vos A et al (2008) Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reprod Biomed Online 17:848–854

    Article  PubMed  Google Scholar 

  5. Cohen J, Wells, D, Munné S (2007) Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril 87:496–503

    Article  PubMed  Google Scholar 

  6. Debrock S, Melotte C, Veermesch J et al (2007) Preimplantation genetic screening for aneuploidy in embryos after in vitro fertilization (IVF) does not improve reproductive outcome in women over 35: a prospective controlled randomized trial. Fertil Steril 88:S237

    Article  Google Scholar 

  7. Geraedts J, Collins J, Gianaroli L et al (2009) What next for preimplantation genetic screening? A polar body approach! Hum Reprod (in press)

  8. Gianaroli L, Magli MC, Munné S et al (1997) Will preimplantation genetic diagnosis assist patients with a poor prognosis to achieve pregnancy? Hum Reprod 12:1762–1767

    Article  CAS  PubMed  Google Scholar 

  9. Gianaroli L, Magli MC, Cavallini G et al (2005) Frequency of aneuploidy in sperm from patients with extremely severe male factor infertility. Hum Reprod 20:2140–2152

    Article  PubMed  Google Scholar 

  10. Goossens V, Harton G, Moutou C et al (2009) ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. Hum Reprod 24:1786–1810

    Article  CAS  PubMed  Google Scholar 

  11. Haaf T, Tresch A, Lambrecht A et al (2010) Outcome of intracytoplasmic sperm injection with and without polar body diagnosis of oocytes. Fertil Steril 93:405–415

    Article  PubMed  Google Scholar 

  12. Handyside AH, Pattinson JK, Penketh RJ et al (1989) Biopsy of human preimplantation embryos and sexing by DNA amplification. Lancet 18:347–349

    Article  Google Scholar 

  13. Hardarson T, Hanson C, Lundin K et al (2008) Preimplantation genetic screening in women of advance maternal age decrease in clinical pregnancy rate: a randomized controlled trial. Hum Reprod 23:2806–2812

    Article  CAS  PubMed  Google Scholar 

  14. Hassold T, Jacobs PA, Leppert M, Sheldon M (1987) Cytogenetic and molecular studies of trisomy 13. J Med Genet 24:725–732

    Article  CAS  PubMed  Google Scholar 

  15. Jansen RP, Bowman MC, Boer KA de et al (2008) What next for preimplantation screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Hum Reprod 23:1476–1478

    Article  PubMed  Google Scholar 

  16. Mastenbroek S, Twisk M, Van Echten-Arends J et al (2007) In vitro fertilization with preimplantation genetic screening. N Engl J Med 357:9–17

    Article  CAS  PubMed  Google Scholar 

  17. Mersereau JE, Pergament E, Zhang X et al (2008) Preimplantation genetic screening to improve in vitro fertilization pregnancy rates: a prospective randomized controlled trial. Fertil Steril 90:1287–1289

    Article  PubMed  Google Scholar 

  18. Meyer L, Klipstein S, Hazlett W et al (2009) A prospective randomized controlled trial of preimplantation genetic screening in the „good prognosis“ patient. Fertil Steril 91:1731–1738

    Article  PubMed  Google Scholar 

  19. Montag M, Ven K van der, Dorn C, Ven H van der (2004) Outcome of laser-assisted polar body biopsy. Reprod Biomed Online 9:425–429

    Article  PubMed  Google Scholar 

  20. Munné S, Dailey T, Sultan KM et al (1995) The use of first polar bodies for preimpantation diagnosis of aneuploidy. Human Reprod 10:1015–1021

    Google Scholar 

  21. Nicolaidis P, Petersen MB (1998) Origin and mechanisms of non-disjunction in human autosomal trisomies. Hum Reprod 13:313–319

    Article  CAS  PubMed  Google Scholar 

  22. Schoolcraft WB, Mandy G, Katz-Jaffe PD et al (2009) Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trial. Fertil Steril 92:157–162

    Article  PubMed  Google Scholar 

  23. Staessen C, Platteau P, Van Assche E et al (2004) Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 19:2849–2858

    Article  PubMed  Google Scholar 

  24. Staessen C, Verpoest W, Donoso P et al (2008) Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Hum Reprod 23:2818–2825

    Article  CAS  PubMed  Google Scholar 

  25. Stevens J, Wale P, Surrey ES, Schoolcraft WB (2004) Is aneuploidy screening for patients aged 35 or over beneficial? A prospective randomized trial. Fertil Steril 82(Suppl 2):249

    Article  Google Scholar 

  26. Twisk M, Mastenbroek S, Wely M van et al (2006) Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database Syst Rev 1:CD005291

    PubMed  Google Scholar 

  27. Ven H van der, Ven K van der, Montag M (2002) Schwangerschaft nach Polkörperbiopsie und Fluoreszenz-in situ-Hybridisierung (FISH) der Chromosomen 13, 16, 18, 21 und 22. Geb Fra 62:585–588

    Article  Google Scholar 

  28. Verlinsky Y, Ginsberg N, Lifchez A et al (1990) Analysis of the first polar body: preconception genetic diagnosis. Hum Reprod 5:826–829

    CAS  PubMed  Google Scholar 

  29. Verlinsky Y, Cieslak J, Freidine M et al (1995) Pregnancies following pre-conception diagnosis of common aneuploidies by fluorescent in-situ hybridization. Hum Reprod 10:1923–1927

    CAS  PubMed  Google Scholar 

  30. Verlinsky Y, Tur-Kaspa I, Cieslak J (2005) Preimplantation testing for chromosomal disorders improves reproductive outcome of poor-prognosis patients. Reprod Biomed Online 11:219–225

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Montag.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montag, M., Köster, M., van der Ven, K. et al. Polkörperdiagnostik. Gynäkologische Endokrinologie 8, 135–140 (2010). https://doi.org/10.1007/s10304-009-0344-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-009-0344-3

Schlüsselwörter

Keywords

Navigation